A 2026 senotherapeutics paper: the record, not the results
npj Aging published a paper with this title on 10 March 2026. Crossref confirms the citation. The findings are not restated here.
Senolytics and senomorphics
Senolytics and senomorphics
Approaches studied to remove senescent cells or to change their secretions. They are not a longevity prescription here. Human lifespan extension is not established here. A disease approval is not an anti-aging approval.
Latest discoveries
Featured research
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming
Zhang W, Song S, Zhang Y, Pan Y, Hu D, Wang Y
Crossref confirms the title, the six authors, the journal npj Aging, and the publication date 10 March 2026. Experimental results are not restated, because they were not taken from the full text.
Bibliographic verification only. No sample size, species, or clinical phase is claimed from this record.
The future
The open questions are measurement, safety and whether a change in a marker changes how people function. Those are research questions, not results.
Sources
Evidence grades stay in the Longevity Explorer. A disease study is not an anti-aging approval. Explorer
Educational information, not medical advice. This site does not publish experimental protocols for personal use and does not recommend genetic therapies, senolytics, or experimental drugs.